Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Rapid Responses to:
|
|
Rapid Responses published:
|
|
|||
|
Eric Freedland 5 Bessom Street, No.318-Marblehead, MA 01945
Send response to journal:
|
I agree with many of Ravnskov’s present and past points, especially regarding cholesterol, saturated fat, and statin drugs. Statin drugs lower C-reactive protein and may confer an anti-inflammatory benefit prior to the lowering of total and LDL cholesterol.1, 2 Like Dr. Ravnskov, I have concerns about their risks.3 It also appears that C-reactive protein is a better marker than lipid profiles suggesting a critical, diffuse inflammatory process in diabetes and CHD.4, 5 Could it be that saturated fat, LDL, and other lipids are fairly benign unless they are in a pro- oxidant environment, and maybe it is the anti-inflammatory effects of the statins that are most beneficial? Perhaps it is the excess calories that are often consumed along with saturated fat (rather than the saturated fat per se) that generate free radical production and exacerbate endothelial dysfunction.6, 7 Saturated fat consumption has been associated with a rise in HDL8 and a lowering of Lp(a).9 Identifying the background diet is often lacking in studies. For example, fiber, which may be low in a high saturated fat diet, has been shown to be a better predictor of insulin levels, weight gain, and other risk factors for CHD than total or saturated fat consumption.10 Metabolic syndrome (along with heart disease and diabetes) is increasing at an alarming rate.11 Since our genes haven’t changed in thousands of years, isn’t it likely that changes in our environment and lifestyles, i.e., exposures, food quality, diet, and exercise patterns, are contributing to our modern epidemics? Lifestyle factors have now been established as keys in preventing and reversing type 2 diabetes12, 13 and CHD,14-16 and evidence supports lowering glycemic load, eliminating trans fats, and emphasizing monounsaturated and omega 3 fatty acids. These dietary measures have been shown to improve glycemic control,17, 18 insulin sensitivity, 19 20 and lipid profiles,17, 18 21 thereby reducing the risk of diabetes19, 22-24 and coronary heart disease.17, 18, 20, 25, 26 Eating smaller, more frequent meals spreads out the “nutrient load,” slows absorption of carbohydrates, helps stabilize insulin and glucose levels,27 may prevent overproduction of free radicals,6, 7, 28 and can lower total and LDL cholesterol which may or may not indicate a lower CHD risk.29-31 There are few long-term studies documenting any diet’s benefits but it would seem that one cannot dismiss a potential role for certain nutritional concepts in disease.32 Exercise and level of fitness may also dictate responses to diet.33, 34 I do agree we need more rational thinking backed by rigorous and unbiased research. 1. Kendrick M. Finally, proof that statins don't work by lowering LDL. BMJ 2001; 323:1145 (electronic response to Kmietowicz, Z. BMJ.com). 2. Ridker PM, Rifai N, Pfeffer MA, Sacks F, Braunwald E. Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators [see comments]. Circulation 1999; 100:230-5. 3. Newman T, Hulley S. Carcinogenicity of lipid-lowering drugs. JAMA 1996; 275:55-60. 4. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000; 342:836-43. 5. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. Jama 2001; 286:327-34. 6. Dandona P, Mohanty P, Ghanim H, et al. The suppressive effect of dietary restriction and weight loss in the obese on the generation of reactive oxygen species by leukocytes, lipid peroxidation, and protein carbonylation. J Clin Endocrinol Metab 2001; 86:355-62. 7. Plotnick GD, Corretti MC, Vogel RA. Effect of antioxidant vitamins on the transient impairment of endothelium-dependent brachial artery vasoactivity following a single high-fat meal. Jama 1997; 278:1682-6. 8. Nicolosi RJ, Wilson TA, Lawton C, Handelman GJ. Dietary effects on cardiovascular disease risk factors: beyond saturated fatty acids and cholesterol. J Am Coll Nutr 2001; 20:421S-427S; discussion 440S-442S. 9. Ginsberg J, Kris-Etherton P, Dennis B, et al. Effects of reducing dietary saturated fatty acids on plasma lipids and lipoproteins in healthy subjects: The Delta Study, Protocol 1. Arterioscler Trhomb Vasc Biol 1998; 18:441-449. 10. Ludwig DS, Pereira MA, Kroenke CH, et al. Dietary fiber, weight gain, and cardiovascular disease risk factors in young adults. Jama 1999; 282:1539-46. 11. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults - Findings from the Third National Health and Nutrition Examination Survey. Jama-Journal of the American Medical Association 2002; 287:356-359. 12. Hu FB, Manson JE, Stampfer MJ, et al. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med 2001; 345:790-7. 13. Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344:1343-50. 14. Fung TT, Willett WC, Stampfer MJ, Manson JE, Hu FB. Dietary patterns and the risk of coronary heart disease in women. Arch Intern Med 2001; 161:1857-62. 15. Brown AA, Hu FB. Dietary modulation of endothelial function: implications for cardiovascular disease. Am J Clin Nutr 2001; 73:673-86. 16. Hu FB, Stampfer MJ, Manson JE, et al. Trends in the incidence of coronary heart disease and changes in diet and lifestyle in women [see comments]. N Engl J Med 2000; 343:530-7. 17. Garg A. High monounsaturated-fat diets for patients with diabetes mellitus: a meta-analysis. Am J Clin Nutr 1998; 67(suppl):577S-82S. 18. Jarvi A, Karlstrom B, Granfeldt Y, Bjorck I, Asp N-G, Vessby B. Improved glycemic control and lipid profile and normalized fibrinolytic activity on a low-glycemic index diet in Type 2 diabetic patients. Diabetes Care 1999; 22:10-18. 19. Hu FB. The role of n-3 polyunsaturated fatty acids in the prevention and treatment of cardiovascular disease. Drugs of Today 2001; 37:49-56. 20. Vessby B, Unsitupa M, Hermansen K, et al. Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: The KANWU Study. Diabetologia 2001; 44:312-9. 21. Ford ES, Liu S. Glycemic index and serum high-density lipoprotein cholesterol concentration among us adults. Arch Intern Med 2001; 161:572- 6. 22. Salmeron J, Ascherio A, Rimm EB, et al. Dietary fiber, glycemic load, and risk of NIDDM in men. Diabetes Care 1997; 20:545-50. 23. Salmeron J, Hu FB, Manson JE, et al. Dietary fat intake and risk of type 2 diabetes in women. Am J Clin Nutr 2001; 73:1019-26. 24. Salmeron J, Manson JE, Stampfer MJ, Colditz GA, Wing AL, Willett WC. Dietary fiber, glycemic load, and risk of non-insulin-dependent diabetes mellitus in women. JAMA 1997; 277:472-7. 25. Liu S, Willett WC, Stampfer MJ, et al. A prospective study of dietary glycemic load, carbohydrate intake, and risk of coronary heart disease in US women. Am J Clin Nutr 2000; 71:1455-61. 26. Harper CR, Jacobson TA. The fats of life: the role of omega-3 fatty acids in the prevention of coronary heart disease. Arch Intern Med 2001; 161:2185-92. 27. Jenkins DJ. Carbohydrate tolerance and food frequency. Br J Nutr 1997; 77 Suppl 1:S71-81. 28. Schinkovitz A, Dittrich P, Wascher TC. Effects of a high-fat meal on resistance vessel reactivity and on indicators of oxidative stress in healthy volunteers. Clin Physiol 2001; 21:404-10. 29. Edelstein SL, Barrett-Connor EL, Wingard DL, Cohn BA. Increased meal frequency associated with decreased cholesterol concentrations; Rancho Bernardo, CA, 1984-1987. Am J Clin Nutr 1992; 55:664-9. 30. Fabry P, Fodor J, Hejl Z, Geizerova H, Balcarova O. Meal frequency and ischaemic heart-disease. Lancet 1968; 2:190-1. 31. Titan SMO, Bingham S, Welch A, et al. Frequency of eating and concentrations of serum cholesterol in the Norfolk population of the European prospective investigation into cancer (EPIC-Norfolk): cross sectional study. BMJ 2001; 323:1286-. 32. Walker WA. Advances in nutrition education for medical students: overview. Am J Clin Nutr 2000; 72:865S-867S. 33. Stefanick ML. Physical activity for preventing and treating obesity- related dyslipoproteinemias. Med Sci Sports Exerc 1999; 31:S609-18. 34. Wei M, Gibbons LW, Kampert JB, Nichaman MZ, Blair SN. Low cardiorespiratory fitness and physical inactivity as predictors of mortality in men with type 2 diabetes [see comments]. Ann Intern Med 2000; 132:605-11. |
|||